Hospital
Catholic Health Initiatives Colorado
Catholic Health Initiatives Colorado was paid $25.26M by Medicaid between Jan 2018 and Dec 2024, across 112 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 27% of everything it billed.
33Billing provider infoCATHOLIC HEALTH INITIATIVES COLORADO
COLORADO SPRINGS, CO 80907
COLORADO SPRINGS, CO 80907
33aNPI1932112125assigned 08/15/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$25.26M
24GClaims783,864
24DCodes billed112
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Colorado
Rank by total paid#6 of 51
Median peer was paid$1.24M
This provider vs. median20×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RICHERT, TADD controls 16+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 136,179 | $3.47M | |
| 2019 | 107,361 | $3.26M | |
| 2020 | 95,682 | $3.09M | |
| 2021 | 116,659 | $3.51M | |
| 2022 | 110,875 | $4.33M | |
| 2023 | 123,155 | $4.15M | |
| 2024incomplete | 93,953 | $3.44M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 27% | 30,461 | 26,731 | $6.90M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 57,205 | 52,470 | $6.02M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 43,453 | 39,411 | $4.18M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 31,735 | 28,031 | $3.16M |
| 80053 | Comprehensive metabolic panel | 4.0% | 67,447 | 60,443 | $1.01M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.9% | 4,482 | 4,099 | $478K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.5% | 2,338 | 2,081 | $373K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.3% | 19,934 | 17,267 | $321K |
| 84484 | 1.2% | 20,220 | 13,021 | $297K | |
| 80320 | 1.1% | 2,929 | 2,516 | $269K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.1% | 4,881 | 4,263 | $266K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 4,170 | 3,869 | $249K |
100 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 3,743 | $243K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,239 | $223K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,882 | $193K |
| 83605 | <1% | 6,716 | $132K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 601 | $102K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 49,518 | $83K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 461 | $79K |
| 93296 | <1% | 4,837 | $77K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 406 | $70K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 151 | $57K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 45,212 | $54K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 30,543 | $50K |
| 43264 | <1% | 59 | $43K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 96 | $31K |
| 87400 | <1% | 1,221 | $30K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 253 | $24K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 95,731 | $19K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 66 | $18K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 165 | $17K |
| 0002A | <1% | 203 | $13K | |
| 80143 | <1% | 253 | $13K | |
| 64415 | <1% | 28 | $11K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 7,811 | $10K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 65 | $10K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 20 | $9K |
| 81001 | <1% | 18,356 | $9K | |
| H0031 | Mental health assessment, by non-physician | <1% | 27 | $9K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 18 | $8K |
| 71045 | Radiologic examination, chest; single view | <1% | 8,716 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 986 | $8K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 91 | $7K |
| 77336 | <1% | 116 | $7K | |
| 80050 | General health panel | <1% | 473 | $7K |
| 80179 | <1% | 185 | $7K | |
| 0001A | <1% | 142 | $6K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 49 | $4K |
| 83880 | <1% | 206 | $4K | |
| G0378 | Hospital observation service, per hour | <1% | 91 | $3K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 45,182 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,343 | $2K |
| 83690 | <1% | 18,002 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,417 | $2K |
| 81003 | <1% | 10,770 | $2K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,520 | $2K |
| 80329 | <1% | 43 | $2K | |
| 76942 | <1% | 18 | $2K | |
| 84703 | <1% | 9,582 | $2K | |
| 77334 | <1% | 22 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 16,313 | $2K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 4,822 | $2K |
| 93975 | <1% | 12 | $1K | |
| 74328 | <1% | 62 | $933.01 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,388 | $768.50 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,046 | $719.16 |
| 82077 | <1% | 4,874 | $648.92 | |
| 77300 | <1% | 18 | $577.29 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 8,632 | $538.04 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13,344 | $469.39 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 283 | $397.41 |
| 85379 | <1% | 26 | $375.60 | |
| 93017 | <1% | 12 | $324.65 | |
| 81025 | <1% | 1,560 | $231.46 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 13 | $223.85 |
| 80076 | <1% | 12 | $191.95 | |
| 80305 | <1% | 1,884 | $135.71 | |
| 84702 | <1% | 114 | $93.70 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,993 | $62.98 |
| 82248 | <1% | 1,455 | $56.12 | |
| 85610 | <1% | 792 | $37.14 | |
| 83735 | <1% | 942 | $30.45 | |
| 87634 | <1% | 14 | $22.07 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 16 | $19.99 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 128 | $13.10 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 1,082 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 26 | $0.00 |
| 84100 | 0% | 33 | $0.00 | |
| 0753T | 0% | 88 | $0.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 109 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 213 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 387 | $0.00 |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 25 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 53 | $0.00 |
| 88313 | 0% | 17 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 65 | $0.00 |
| 99152 | 0% | 16 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 54,957 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 3,461 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 116 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 547 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 311 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 1,266 | $0.00 |
| C1769 | Guide wire | 0% | 156 | $0.00 |
| 85027 | 0% | 33 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 19 | $0.00 |
| C9290 | Injection, bupivacaine liposome, 1 mg | 0% | 72 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 13 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 56 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 0% | 19 | $0.00 |
| 96376 | 0% | 49 | $0.00 | |
| 86140 | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRICHERT, TADD (GROUP VP FINANCE)
Parent organizationCATHOLIC HEALTH INITIATIVES
| Provider | Location | Paid |
|---|---|---|
| Catholic Health Initiatives Colorado | Pueblo, CO | $23.66M |
| Catholic Health Initiatives Colorado | Lakewood, CO | $8.91M |
| Catholic Health Initiatives Colorado | Canon City, CO | $8.35M |
| Catholic Health Iniatives Colorado | Westminster, CO | $7.55M |
| Catholic Health Initiatives Colorado | Canon City, CO | $6.39M |
| Catholic Health Initiatives Colorado | Durango, CO | $5.98M |
| Longmont United Hospital | Longmont, CO | $5.25M |
| Catholic Health Initiatives Colorado | Lakewood, CO | $4.40M |
| Commonspirit Kansas, INC. | Ulysses, KS | $2.77M |
| Commonspirit Kansas, INC. | Garden City, KS | $1.22M |
| Catholic Health Initiatives Colorado | Fort Morgan, CO | $1.17M |
| Catholic Health Iniatives Colorado | Frisco, CO | $691K |
| ST. Vincent Infirmary Medical Center | Sherwood, AR | $469K |
| Commonspirit Kansas, INC. | Dodge City, KS | $267K |
| Catholic Health Initiatives Colorado | Pueblo, CO | $153K |
| Catholic Health Initiatives Colorado | Colorado Springs, CO | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.